Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Meta-analysis of the prognostic and diagnostic significance of serum/plasma osteopontin in hepatocellular carcinoma.

Cheng J, Wang W, Sun C, Li M, Wang B, Lv Y.

J Clin Gastroenterol. 2014 Oct;48(9):806-14. doi: 10.1097/MCG.0000000000000018.

PMID:
24247813
[PubMed - in process]
2.

Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis.

Wan HG, Xu H, Gu YM, Wang H, Xu W, Zu MH.

Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):706-14. doi: 10.1016/j.clinre.2014.06.008. Epub 2014 Jul 14.

PMID:
25034355
[PubMed - in process]
3.

Prognostic significance of osteopontin in hepatocellular carcinoma: a meta-analysis.

Zhang CH, Xu GL, Jia WD, Ge YS, Li JS, Ma JL, Ren WH.

Int J Cancer. 2012 Jun 1;130(11):2685-92. doi: 10.1002/ijc.26301. Epub 2011 Sep 14.

PMID:
21780114
[PubMed - indexed for MEDLINE]
4.

Prognostic role of pre-treatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis.

Cheng J, Wang W, Zhang Y, Liu X, Li M, Wu Z, Liu Z, Lv Y, Wang B.

PLoS One. 2014 Jan 30;9(1):e87011. doi: 10.1371/journal.pone.0087011. eCollection 2014. Review.

PMID:
24498011
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.

Lv Y, Wang W, Jia WD, Sun QK, Huang M, Zhou HC, Xia HH, Liu WB, Chen H, Sun SN, Xu GL.

Eur J Surg Oncol. 2013 Oct;39(10):1129-35. doi: 10.1016/j.ejso.2013.06.023. Epub 2013 Jul 31.

PMID:
23916473
[PubMed - indexed for MEDLINE]
6.

Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis.

Jia X, Liu J, Gao Y, Huang Y, Du Z.

Arch Med Res. 2014 Oct;45(7):580-8. doi: 10.1016/j.arcmed.2014.11.002. Epub 2014 Nov 13.

PMID:
25446613
[PubMed - in process]
7.

Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma.

Abu El Makarem MA, Abdel-Aleem A, Ali A, Saber R, Shatat M, Rahem DA, Sayed D.

Ann Hepatol. 2011 Jul-Sep;10(3):296-305.

PMID:
21677331
[PubMed - indexed for MEDLINE]
8.

Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.

Nabih MI, Aref WM, Fathy MM.

Arab J Gastroenterol. 2014;15(3-4):103-7. doi: 10.1016/j.ajg.2014.08.002. Epub 2014 Sep 22.

PMID:
25249230
[PubMed - in process]
9.

Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.

Zhou Y, Yin X, Ying J, Zhang B.

BMC Cancer. 2012 Jan 16;12:17. doi: 10.1186/1471-2407-12-17. Review.

PMID:
22244200
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma.

Sun J, Xu HM, Zhou HJ, Dong QZ, Zhao Y, Fu LY, Hei ZY, Ye QH, Ren N, Jia HL, Qin LX.

J Cancer Res Clin Oncol. 2010 Jan;136(1):1-7. doi: 10.1007/s00432-009-0629-x.

PMID:
19593583
[PubMed - indexed for MEDLINE]
11.

Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.

Xu XS, Qu K, Liu C, Zhang YL, Liu J, Song YZ, Zhang P, Liu SN, Chang HL.

World J Gastroenterol. 2012 Dec 28;18(48):7242-50. doi: 10.3748/wjg.v18.i48.7242.

PMID:
23326129
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma.

Ying X, Zhao Y, Wang JL, Zhou X, Zhao J, He CC, Guo XJ, Jin GH, Wang LJ, Zhu Q, Han SX.

Oncol Rep. 2014 Oct;32(4):1550-6. doi: 10.3892/or.2014.3367. Epub 2014 Jul 30.

PMID:
25109745
[PubMed - in process]
13.

Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.

Kim J, Ki SS, Lee SD, Han CJ, Kim YC, Park SH, Cho SY, Hong YJ, Park HY, Lee M, Jung HH, Lee KH, Jeong SH.

Am J Gastroenterol. 2006 Sep;101(9):2051-9. Epub 2006 Jul 18.

PMID:
16848813
[PubMed - indexed for MEDLINE]
14.

Diagnostic accuracy of des-gamma-carboxy prothrombin versus α-fetoprotein for hepatocellular carcinoma: A systematic review.

Li C, Zhang Z, Zhang P, Liu J.

Hepatol Res. 2014 Oct;44(10):E11-25. doi: 10.1111/hepr.12201. Epub 2013 Aug 19.

PMID:
23834468
[PubMed]
15.

Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.

Liu J, Ma Q, Zhang M, Wang X, Zhang D, Li W, Wang F, Wu E.

Eur J Cancer. 2012 Oct;48(15):2328-38. doi: 10.1016/j.ejca.2012.03.001. Epub 2012 Mar 27. Review.

PMID:
22459764
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Clinical utility of plasma glypican-3 and osteopontin as biomarkers of hepatocellular carcinoma.

Lee HJ, Yeon JE, Suh SJ, Lee SJ, Yoon EL, Kang K, Yoo YJ, Kim JH, Seo YS, Yim HJ, Byun KS.

Gut Liver. 2014 Mar;8(2):177-85. doi: 10.5009/gnl.2014.8.2.177. Epub 2013 Dec 24.

PMID:
24672660
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.

Xiao WK, Chen D, Li SQ, Fu SJ, Peng BG, Liang LJ.

BMC Cancer. 2014 Feb 21;14:117. doi: 10.1186/1471-2407-14-117.

PMID:
24559042
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

Shang S, Plymoth A, Ge S, Feng Z, Rosen HR, Sangrajrang S, Hainaut P, Marrero JA, Beretta L.

Hepatology. 2012 Feb;55(2):483-90. doi: 10.1002/hep.24703. Epub 2011 Dec 19.

PMID:
21953299
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma.

Xie H, Song J, Du R, Liu K, Wang J, Tang H, Bai F, Liang J, Lin T, Liu J, Fan D.

Dig Liver Dis. 2007 Feb;39(2):167-72. Epub 2006 Dec 11.

PMID:
17161983
[PubMed - indexed for MEDLINE]
20.

The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma.

Zhang H, Ye QH, Ren N, Zhao L, Wang YF, Wu X, Sun HC, Wang L, Zhang BH, Liu YK, Tang ZY, Qin LX.

J Cancer Res Clin Oncol. 2006 Nov;132(11):709-17. Epub 2006 Jun 20.

PMID:
16786357
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk